Evidence check: Östradiol in the context of Allergie

The question of estradiol in the context of allergies is scientifically relevant, but the provided contexts contain no direct information on this topic. Estradiol, a primary female sex hormone, modulates the immune system in complex ways: it can have both pro-inflammatory and anti-inflammatory effects depending on concentration, receptor type, and tissue. In allergy research, observational studies suggest that fluctuations in estradiol levels (e.g., during the menstrual cycle, pregnancy, or hormone replacement therapy) may influence the severity of allergic conditions such as asthma, rhinitis, or eczema. Some studies indicate increased IgE production or mast cell activation under estrogen influence. However, the evidence is largely mechanistic or from animal models; large randomized trials are lacking. Direct-to-consumer tests that link estradiol or genetic variants in estrogen metabolism (e.g., CYP1A1, COMT) to allergy risk often overstate clinical relevance. Individual hormonal and immune status is multifactorial. Conclusion: A connection is biologically plausible, but the evidence is mixed and insufficient for specific recommendations. Allergy management should rely on established allergological methods, not on hormone profiles from consumer tests.